Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development

Cancers (Basel). 2022 Jan 7;14(2):297. doi: 10.3390/cancers14020297.

Authors

Vladimir Tolmachev^{1

2}, Anzhelika Vorobyeva^{1

2}

Affiliations

¹ Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
² Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.

Abstract

The interest in using targeted radiopharmaceuticals in nuclear oncology has increased in recent years and continues to grow [...].

Publication types

Editorial